These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 11755693)

  • 1. Differential roles for nicotinic and muscarinic cholinergic receptors in sustained visuo-spatial attention? A study using a 5-arm maze protocol in mice.
    Leblond L; Beaufort C; Delerue F; Durkin TP
    Behav Brain Res; 2002 Jan; 128(1):91-102. PubMed ID: 11755693
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of central cholinergic receptor sub-types in spatial working memory: a five-arm maze task in mice provides evidence for a functional role of nicotinic receptors in mediating trace access processes.
    Maviel T; Durkin TP
    Neuroscience; 2003; 120(4):1049-59. PubMed ID: 12927210
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nicotinic, muscarinic and dopaminergic actions in the ventral hippocampus and the nucleus accumbens: effects on spatial working memory in rats.
    Kim JS; Levin ED
    Brain Res; 1996 Jul; 725(2):231-40. PubMed ID: 8836529
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Muscarinic and nicotinic receptors synergistically modulate working memory and attention in humans.
    Ellis JR; Ellis KA; Bartholomeusz CF; Harrison BJ; Wesnes KA; Erskine FF; Vitetta L; Nathan PJ
    Int J Neuropsychopharmacol; 2006 Apr; 9(2):175-89. PubMed ID: 15877932
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dissociable contributions of mediodorsal and anterior thalamic nuclei in visual attentional performance: A comparison using nicotinic and muscarinic cholinergic receptor antagonists.
    Mantanona CP; Božič T; Chudasama Y; Robbins TW; Dalley JW; Alsiö J; Pienaar IS
    J Psychopharmacol; 2020 Dec; 34(12):1371-1381. PubMed ID: 33103560
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Muscarinic and nicotinic receptor modulation of object and spatial n-back working memory in humans.
    Green A; Ellis KA; Ellis J; Bartholomeusz CF; Ilic S; Croft RJ; Phan KL; Nathan PJ
    Pharmacol Biochem Behav; 2005 Jul; 81(3):575-84. PubMed ID: 15936063
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A 5-arm maze enables parallel measures of sustained visuo-spatial attention and spatial working memory in mice.
    Durkin TP; Beaufort C; Leblond L; Maviel T
    Behav Brain Res; 2000 Nov; 116(1):39-53. PubMed ID: 11090884
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interaction between the cholinergic system and CRH in the modulation of spatial discrimination learning in mice.
    Steckler T; Holsboer F
    Brain Res; 2001 Jul; 906(1-2):46-59. PubMed ID: 11430861
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of concurrent manipulations of nicotinic and muscarinic receptors on spatial and passive avoidance learning.
    Riekkinen P; Sirviö J; Aaltonen M; Riekkinen P
    Pharmacol Biochem Behav; 1990 Nov; 37(3):405-10. PubMed ID: 2087481
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Strain specificity and cholinergic modulation of visuospatial attention in three inbred mouse strains.
    Pattij T; Janssen MC; Loos M; Smit AB; Schoffelmeer AN; van Gaalen MM
    Genes Brain Behav; 2007 Aug; 6(6):579-87. PubMed ID: 17116168
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of muscarinic and nicotinic receptor antagonists on attention and working memory.
    McQuail JA; Burk JA
    Pharmacol Biochem Behav; 2006 Dec; 85(4):796-803. PubMed ID: 17196638
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impairment of radial-arm maze performance in rats following lesions involving the cholinergic medial pathway: reversal by arecoline and differential effects of muscarinic and nicotinic antagonists.
    McGurk SR; Levin ED; Butcher LL
    Neuroscience; 1991; 44(1):137-47. PubMed ID: 1770993
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nicotinic-dopaminergic relationships and radial-arm maze performance in rats.
    McGurk SR; Levin ED; Butcher LL
    Behav Neural Biol; 1989 Jul; 52(1):78-86. PubMed ID: 2757586
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Blockade of muscarinic, rather than nicotinic, receptors impairs attention, but does not interact with serotonin depletion.
    Ruotsalainen S; Miettinen R; MacDonald E; Koivisto E; Sirviö J
    Psychopharmacology (Berl); 2000 Feb; 148(2):111-23. PubMed ID: 10663425
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The interactive effects of nicotinic and muscarinic cholinergic receptor inhibition on fear conditioning in young and aged C57BL/6 mice.
    Feiro O; Gould TJ
    Pharmacol Biochem Behav; 2005 Feb; 80(2):251-62. PubMed ID: 15680178
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An anti-nicotinic cognitive challenge model using mecamylamine in comparison with the anti-muscarinic cognitive challenge using scopolamine.
    Baakman AC; Alvarez-Jimenez R; Rissmann R; Klaassen ES; Stevens J; Goulooze SC; den Burger JCG; Swart EL; van Gerven JMA; Groeneveld GJ
    Br J Clin Pharmacol; 2017 Aug; 83(8):1676-1687. PubMed ID: 28217868
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of nicotinic and muscarinic acetylcholine receptors in attention.
    Mirza NR; Stolerman IP
    Psychopharmacology (Berl); 2000 Feb; 148(3):243-50. PubMed ID: 10755737
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acute nicotine interactions with nicotinic and muscarinic antagonists: working and reference memory effects in the 16-arm radial maze.
    Levin ED; Kaplan S; Boardman A
    Behav Pharmacol; 1997 Jun; 8(2-3):236-42. PubMed ID: 9833018
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of the cognitive effects of combined muscarinic and nicotinic blockade.
    Levin ED; Rose JE; McGurk SR; Butcher LL
    Behav Neural Biol; 1990 Jan; 53(1):103-12. PubMed ID: 1967931
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Residential maze as a task for testing rats' maze learning ability: effects of hippocampal lesions and cholinergic receptor antagonists.
    Yamada K; Kawai H; Iwasaki T; Ichitani Y
    Neuroreport; 2002 Oct; 13(14):1759-64. PubMed ID: 12395118
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.